Expression of S100A7 in oral potentially malignant disorders: An immunohistochemical study

Conclusions: S100A7 antigen showed significant immune expression in OPMDs and may be used as a marker for early diagnosis and precision therapy.

Source: Journal of Oral and Maxillofacial Pathology - October 17, 2022 Category: ENT & OMF Authors: Pushpanjali Das Revati Deshmukh Source Type: research